CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Overview of attention for article published in Biomarker Research, February 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#21 of 389)
High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

news: 1 news outlet

patent: 22 patents

Citations

dimensions_citation: 207 Dimensions

Readers on

mendeley: 221 Mendeley

Summary News Patents Dimensions citations

So far, Altmetric has seen 22 patents that reference this research output.

Anti-CD123 antibodies and conjugates and derivatives thereof

Grant US-11897961-B2

United States of America

CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM…

Application WO-2023247634-A1

World Intellectual Property Organisation (WIPO)

CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM…

Application EP-4296280-A1

European Patent Office

Therapeutic combinations comprising anti-CD123 immunoconjugates

Grant US-11701428-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 18 additional patents.